Cargando…
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
PURPOSE: Mistletoe extract (ME) is widely used for patients with cancer to support therapy and to improve quality of life (QoL). However, its use is controversial due to suboptimal trials and a lack of data supporting its intravenous administration. MATERIALS AND METHODS: This phase I trial of intra...
Autores principales: | Paller, Channing J., Wang, Lin, Fu, Wei, Kumar, Rajendra, Durham, Jennifer N., Azad, Nilofer S., Laheru, Daniel A., Browner, Ilene, Kachhap, Sushant K., Boyapati, Kavya, Odeny, Thomas, Armstrong, Deborah K., Meyer, Christian F., Gaillard, Stephanie, Brahmer, Julie R., Page, Ivelisse, Wang, Hao, Diaz, Luis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973409/ https://www.ncbi.nlm.nih.gov/pubmed/36860652 http://dx.doi.org/10.1158/2767-9764.CRC-23-0002 |
Ejemplares similares
-
Mistletoe as an Oxytoxic
Publicado: (1878) -
The Mistletoe Bough
Publicado: (1871) -
Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
por: Nauman, Gina, et al.
Publicado: (2018) -
Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study
por: Steele, Megan L., et al.
Publicado: (2014) -
Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study
por: Schläppi, Marc, et al.
Publicado: (2016)